Dr. Adhish K. Agarwal, MD

Dr. Agarwal practices at University of Utah Hospitals and Clinics - Unit in Salt Lake City, Utah.

Dr. Agarwal's NPI, 1164424750, was assigned on August 12, 2005. Dr. Agarwal holds Utah license 4929797-1205.

Dr. Agarwal's primary practice is University of Utah Hospitals and Clinics - Unit, at 50 North Medical Drive, Salt Lake City, UT 84132 in Salt Lake County. The practice phone is (801) 581-2337.

Dr. Agarwal's primary practice is University of Utah Hospitals and Clinics - Unit in Salt Lake City, Utah. Dr. Agarwal is also affiliated with University of Utah Hospital. The medical group on file is University of Utah Health. Dmand AI also links Dr. Agarwal to 1 more hospital, 1 dialysis center and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Agarwal practices, 5 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Agarwal's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Agarwal is licensed in Utah.

CMS data shows 157 Medicare services from Dr. Agarwal across 3 procedure codes in 2024, for 75 Medicare patients. Medicare paid $8,001 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 75 Medicare patients who saw Dr. Agarwal in 2024. The largest group is 65 to 74, with 32 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 16% are also on Medicaid. Their average risk score is 2.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Agarwal's median patient age at 75, with 47% women.

In 2024, Dr. Agarwal wrote 190 Medicare Part D claims for 35 patients. 98% of them were for generic drugs. CMS names the drug for 96 of them, across 3 drugs with 11 or more claims each, at $1,021 in total drug cost. In 2023, CMS named 141 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Agarwal for performance year 2024, reported as part of a group. Dr. Agarwal accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 13 papers to Dr. Agarwal, published from 2017 to 2024. 2020 was the busiest year, with 3. The most frequent topics are Renal Insufficiency, Chronic, Heart Failure and Kidney Failure, Chronic. Dr. Agarwal has published most often in Clin J Am Soc Nephrol. Dr. Agarwal's most frequent co-authors are Monique Eun Hee Cho, Monique, CHO, Srinivasan Beddhu, MD and Kalani Lukela Raphael, MD.

Dmand AI links Dr. Agarwal to 1 clinical trial.

CMS Open Payments shows 12 general payments to Dr. Agarwal from 6 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Amgen Inc. paid the most, $70. It also lists 3 research payments totaling $847 in 2018.